Carine W Maurer1, Kathrin LaFaver2, Rezvan Ameli3, Ryan Toledo4, Mark Hallett5. 1. Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. Electronic address: carine.maurer@nih.gov. 2. Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA; University of Louisville, Department of Neurology, Louisville, KY, USA. Electronic address: kathrin.lafaver@gmail.com. 3. Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. Electronic address: amelir@mail.nih.gov. 4. Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. Electronic address: ryan.toledo21@gmail.com. 5. Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. Electronic address: hallettm@ninds.nih.gov.
Abstract
INTRODUCTION: While the presence of co-existing psychological stressors has historically been used as a supportive factor in the diagnosis of functional neurological disorders, many patients with functional neurological disorders deny the presence of these stressors. The stress response circuitry in these patients remains largely unexplored. METHODS: We performed an observational study examining biological stress levels in patients with functional movement disorders as compared with matched healthy controls. Specifically, we compared levels of circulating cortisol, the end-product of the hypothalamic-pituitary-adrenal axis. Salivary cortisol samples were collected from patients with "clinically definite" functional movement disorders (n = 33) and their age- and sex-matched controls (n = 33). Collections were performed at five standardized time points, reflecting participants' diurnal cortisol cycles. To rule out confounders, participants also underwent extensive psychological assessment including Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Hamilton Anxiety Rating Scale, and Hamilton Rating Scale for Depression. RESULTS: Patients with functional movement disorders did not differ from matched controls with respect to levels of circulating cortisol. CONCLUSION: We demonstrate that current stress levels are not altered in patients with functional movement disorders. Our results warrant careful review of current management of patients with functional neurological symptoms, and suggest that the insistence on heightened stress levels in these patients is unjustified. Published by Elsevier Ltd.
INTRODUCTION: While the presence of co-existing psychological stressors has historically been used as a supportive factor in the diagnosis of functional neurological disorders, many patients with functional neurological disorders deny the presence of these stressors. The stress response circuitry in these patients remains largely unexplored. METHODS: We performed an observational study examining biological stress levels in patients with functional movement disorders as compared with matched healthy controls. Specifically, we compared levels of circulating cortisol, the end-product of the hypothalamic-pituitary-adrenal axis. Salivary cortisol samples were collected from patients with "clinically definite" functional movement disorders (n = 33) and their age- and sex-matched controls (n = 33). Collections were performed at five standardized time points, reflecting participants' diurnal cortisol cycles. To rule out confounders, participants also underwent extensive psychological assessment including Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Hamilton Anxiety Rating Scale, and Hamilton Rating Scale for Depression. RESULTS:Patients with functional movement disorders did not differ from matched controls with respect to levels of circulating cortisol. CONCLUSION: We demonstrate that current stress levels are not altered in patients with functional movement disorders. Our results warrant careful review of current management of patients with functional neurological symptoms, and suggest that the insistence on heightened stress levels in these patients is unjustified. Published by Elsevier Ltd.
Entities:
Keywords:
Conversion disorder; Cortisol; Functional movement disorders; Hypothalamic-pituitary adrenal axis; Psychogenic movement disorders; Stress
Authors: Karin Roelofs; Philip Spinhoven; Pieter Sandijck; Franny C Moene; Kees A L Hoogduin Journal: J Nerv Ment Dis Date: 2005-08 Impact factor: 2.254
Authors: Isaiah Kletenik; Stefan H Sillau; Sanaz Attaripour Isfahani; Kathrin LaFaver; Mark Hallett; Brian D Berman Journal: Mov Disord Clin Pract Date: 2019-12-13
Authors: Carine W Maurer; Victoria D Liu; Kathrin LaFaver; Rezvan Ameli; Tianxia Wu; Ryan Toledo; Steven A Epstein; Mark Hallett Journal: Parkinsonism Relat Disord Date: 2016-06-16 Impact factor: 4.891
Authors: Steven A Epstein; Carine W Maurer; Kathrin LaFaver; Rezvan Ameli; Stephen Sinclair; Mark Hallett Journal: Psychosomatics Date: 2016-04-29 Impact factor: 2.386
Authors: Carine W Maurer; Kathrin LaFaver; Rezvan Ameli; Steven A Epstein; Mark Hallett; Silvina G Horovitz Journal: Neurology Date: 2016-07-06 Impact factor: 9.910
Authors: Carine W Maurer; Kathrin LaFaver; Gaurang S Limachia; Geanna Capitan; Rezvan Ameli; Stephen Sinclair; Steven A Epstein; Mark Hallett; Silvina G Horovitz Journal: Neurology Date: 2018-10-10 Impact factor: 9.910
Authors: Christina van der Feltz-Cornelis; Sally Brabyn; Jonathan Ratcliff; Danielle Varley; Victoria Allgar; Simon Gilbody; Chris Clarke; Dimitris Lagos Journal: Brain Behav Immun Health Date: 2021-02-24